ギヤン・バリ症候群の予後は,ギヤン・バリ症候群の予後である
Lancet (London, England)
|May 25, 1985
まとめ
ギラン・バリ症候群の結果を予測することは可能である. 換気装置を必要とする重度の欠乏症と3週間以内に改善しない状態は,ギヤン=バリ症候群の患者の予後が悪いことを示している.
科学分野:
- 神経学 神経学とは
- クリニカル・メディシン 臨床医学
背景:
- ギラン・バリ症候群 (Guillain-Barré syndrome) は珍しい神経学的疾患である.
- 患者の管理において,正確な予後予測は極めて重要です.
研究 の 目的:
- ギラン・バリ症候群の臨床的予測要因を特定する.
- 特定の臨床的特徴の予後的価値を評価する.
主な方法:
- 以前の治療試験から71人の患者の症例記録を遡及的に分析した.
- 患者のアウトカムに対する臨床プレゼンテーションの特徴の評価.
主要な成果:
- 機械的な換気を必要とする深刻な最大赤字は,主要な負の予後要因でした.
- また,ピーク赤字に達してから3週間以内に改善しない場合も,予後不良を示唆しています.
- 換気装置が必要な患者と改善が遅れた患者は,不良の結果の86%のリスクがありました.
結論:
- 呼吸器の必要性や回復の遅さなどの初期の臨床症状は,ギヤン=バリ症候群の予後を予測する上で重要である.
- これらの発見は,ギラン・バリ症候群のリスク分層化と治療計画における臨床医を助けることができます.
関連する概念動画
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Secondary Spinal Cord Injury llI: Pathophysiology
Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...


